In Depth 11 Jun 2025
Can gene therapy treat vision loss?
Since the approval of Luxturna, there has been a wave of companies developing treatments with the potential to cure different forms of genetic blindness.
- Latest Posts
Best in Biotech 10 Jun 2025
Pushing biotech forward in France: 18 companies to know about
France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 18 top French biotech companies!
News and Trends 9 Jun 2025
First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field?
Antibiotic development has seen a slump in recent decades. Now, after 50 years, a new antibiotic has been created to tackle bacterial infections.
News and Trends 6 Jun 2025
Beyond CRISPR: What CAST could bring to genome editing
Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in research.
Podcast 6 Jun 2025
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
This week, Paolo Di Giorgio and Regina Hodits of Angelini Ventures share their perspective on the current fundraising landscape.
In Depth 4 Jun 2025
The biggest biotech funding rounds in May 2025
The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in May 2025.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 4 Jun 2025
ASCO 2025: key highlights in cancer therapeutics
Discover the major highlights from ASCO, according to researchers and drug developers who attended the convention.
In Depth 3 Jun 2025
How biotechs are developing novel treatments to tackle high cholesterol
Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.
News and Trends 2 Jun 2025
Top biotech deals in May 2025
Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and antibodies.
In Depth 30 May 2025
London: A closer look at the UK capital’s world-renowned biotech hub
Take a closer look at London’s biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure.
Podcast 30 May 2025
The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie
Trying to predict where the market for biotech investment is heading is risky but for experts like Baker McKenzie’s Roel Meers, understanding where the market is moving is where he eats.
In Depth 28 May 2025
New weight loss drugs: Biotech’s mission to end obesity
Find out more about biotech’s mission to end obesity, as we look at the new weight loss drugs that are in development.
ADVERTISEMENT
